why choose us

First received: August 23, 2022

Clinical Trial: ADJUnct Semaglutide Treatment in Type 1 Diabetes

Study Status: Completed

Recruit Status: RECRUITING

Condition: Type 1 Diabetes

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Once Weekly Semaglutide in Adults With Obesity and Inadequately Controlled Type 1 Diabetes Using Hybrid Closed-Loop System.

Brief Summary: The purpose of this study is to assess the use of once weekly semaglutide injection in inadequately controlled obese adults with type 1 diabetes (T1D) using FDA-approved hybrid closed-loop therapies.

Read more